Flexible Endoscopes Market Set To Reach USD 3.07 Billion By 2030

(MENAFN- GetNews)


"North America accounted for the largest share of the global flexible endoscopes market due to the high prevalence of chronic diseases, such as gastrointestinal disorders, cancer, and neurological conditions, which require frequent diagnostic and therapeutic endoscopic procedures"Browse 443 market data Tables and 48 Figures spread through 329 Pages and in-depth TOC on "Flexible Endoscopes Market by Type (Colonoscope, Laryngoscope, Bronchoscope, Other Types), Application (Laparoscopy, Mediastinoscopy, Obstetrics, Arthroscopy, Cystoscopy, Mediastinoscopy), End User (Hospitals, ASCs, Clinics), and Region – Global Forecast to 2030

The global flexible endoscopes market is projected to grow from USD 2.38 billion in 2025 to USD 3.07 billion by 2030 , expanding at a robust CAGR of 5.1% . This market growth reflects a significant shift in the healthcare landscape toward minimally invasive procedures, enhanced diagnostic accuracy, and patient-friendly solutions.

Market Growth Drivers

Several critical factors are fueling the growing demand for flexible endoscopes:

• ✅ Rising Demand for Minimally Invasive Procedures Minimally invasive approaches are preferred due to lower complications, quicker patient recovery, and reduced hospitalization costs.
• ✅ Prevalence of Gastrointestinal & Respiratory Disorders Conditions such as GERD, colorectal cancer, and COPD are increasing, driving the need for advanced diagnostic tools.
• ✅ Technological Advancements Innovations in imaging quality, maneuverability, and AI-driven diagnostic support are making endoscopes more efficient and precise.
• ✅ Expanding Geriatric Population & Better Reimbursement Policies Growing elderly populations and favorable insurance reimbursement schemes promote more routine diagnostic procedures.

Download PDF Brochure:

Market Challenges

Despite growth opportunities, the market faces notable challenges:

• High device costs
• Risk of cross-contamination despite reprocessing
• Availability of alternative diagnostic techniques
• Shortage of skilled professionals
• Regulatory hurdles in various markets

Leading Players Shaping the Market

Olympus Corporation (Japan)

A global leader in flexible endoscopy solutions, Olympus provides advanced gastrointestinal and surgical endoscopes with AI integration and superior imaging systems.

Key Moves :

• ✔️ May 2025: FDA 510(k) clearance for EZ1500 series with Extended Depth of Field (EDOF) tech
• ✔️ Jan 2024: Acquisition of Taewoong Medical Co., Ltd.
• ✔️ May 2023: Launch of two advanced bronchoscopes under the EVIS X1 Endoscopy System

Karl Storz SE & CO. Kg (Germany)

Offering over 10,000 products , Karl Storz serves key clinical areas such as bronchoscopy and neuroendoscopy, supported by a global network of 70 subsidiaries.

Key Moves :

• ✔️ Jan 2025: Acquisition of ANKLIN (Swiss distributor) to enhance direct sales
• ✔️ Aug 2024: Acquisition of Surgical, Inc. (US) to expand advanced surgical solutions
• ✔️ Collaboration with FUJIFILM for joint GI endoscope marketing

Request Sample Pages :

Boston Scientific Corporation (US)

A major player delivering a wide range of flexible endoscopic solutions globally, particularly in gastroenterology and pulmonology.

Other prominent players include FUJIFILM Corporation (Japan) , HOYA Corporation (Japan) , Nipro (Japan) , EndoMed Systems GmbH (Germany) , Richard Wolf GmbH (Germany) , and Ambu A/S (Denmark) .

Market Segmentations

The upper gastrointestinal videoscope subsegment accounted for the largest share in 2024.

By type, the flexible endoscopes market is segmented into upper gastrointestinal endoscopes, colonoscopes, broncoscopes, sigmoidoscopes, laryngoscopes, pharyngoscopes, duodenoscopes, nasopharyngoscopes, rhinoscopes, and other types. The upper gastrointestinal endoscopes segment accounted for the largest market share in 2024. The segment is further divided into upper gastrointestinal videoscope and upper gastrointestinal fiberscope. Among these, the upper gastrointestinal videoscope segment accounted for a significant market share in 2024, due to the critical role of upper gastrointestinal videoscope in diagnosing and treating a wide range of upper GI conditions, such as GERD, ulcers, Barrett's esophagus, and gastric cancers. These devices utilize advanced video chip technology that delivers high-resolution, real-time imaging, enabling accurate diagnosis and guided therapeutic interventions. Their flexibility allows for precise navigation through complex anatomical regions, which makes them essential in procedures like foreign object removal, biopsies, and bleeding control. Moreover, their extensive use in hospital and outpatient settings, supported by skilled professionals and ongoing technology upgrades, further solidifies their dominant market position within the flexible endoscopes market.

The hospitals segment accounted for the largest share in 2024.

By end user, the flexible endoscopes market is segmented into hospitals, ambulatory surgical centers (ASCs), clinics, and other end users (Diagnostic centers, mobile endoscopy facilities, and office-based endoscopy service providers). Among these, the hospitals segment accounted for the largest market share in 2024, owing to the high patient inflow for diagnostic and therapeutic procedures, which demand advanced infrastructure and skilled medical professionals. Hospitals are equipped with comprehensive surgical setups, enabling the use of flexible endoscopes across various specialties, such as gastroenterology, pulmonology, and urology. Additionally, increasing funding from both public and private sectors has supported hospitals in upgrading to next-generation endoscopic equipment, improving procedural efficiency and outcomes. Hospitals often serve as referral centers for complex cases, increasing the volume of endoscopic procedures. These factors collectively drive hospital-based endoscopy adoption, reinforcing the dominant position of the hospitals segment in the market.

North America dominated the global flexible endoscopes market in 2024

The flexible endoscopes market is segmented into five major regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global flexible endoscopes market due to the high prevalence of chronic diseases, such as gastrointestinal disorders, cancer, and neurological conditions, which require frequent diagnostic and therapeutic endoscopic procedures. According to the CDC (October 2024), six in ten Americans have at least one chronic disease, and four in ten suffer from multiple conditions, significantly driving the demand for minimally invasive solutions, like flexible endoscopes. Additionally, the region benefits from the strong presence of key endoscope manufacturers and continuous technological innovation. The region's well-established healthcare infrastructure, favorable reimbursement policies, and high awareness among patients and physicians further contribute to the region's early adoption of endoscopic procedures. Moreover, the increasing investment by healthcare facilities in upgrading diagnostic capabilities and the presence of trained professionals reinforce North America's leadership in the flexible endoscopes market.

MENAFN19092025003238003268ID1110083138